Circulating tumor DNA (ctDNA) in predicting residual disease after neoadjuvant chemoradiotherapy (nCRT) for esophageal squamous cell carcinoma (ESCC).

Liu, ZC; Yang, Y; Liu, J; Zhu, L; Yu, H; Zhu, MJ; Yang, XLJ; Xiang, JX; Li, HY; Li, B; Li, ZG

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):